gemcabene has been researched along with Hypertriglyceridemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegele, RA; Tsimikas, S | 1 |
| Bays, HE; Dujovne, CA; MacDougall, DE; McKenney, JM; Nyberg, J; Schrott, HG; Zema, MJ | 1 |
1 trial(s) available for gemcabene and Hypertriglyceridemia
| Article | Year |
|---|---|
Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Caproates; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Treatment Outcome; Triglycerides | 2003 |
1 other study(ies) available for gemcabene and Hypertriglyceridemia
| Article | Year |
|---|---|
Lipid-Lowering Agents.
Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Benzimidazoles; Caproates; Cholesterol, HDL; Cholesterol, LDL; Diacylglycerol O-Acyltransferase; Dicarboxylic Acids; Dyslipidemias; Ezetimibe; Fatty Acids; Genetic Therapy; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoprotein(a); Oligonucleotides; RNA, Small Interfering | 2019 |